Irritable bowel syndrome remains a global challenge impacting the life of patients.
Patients continue to suffer and progress is limited.
There is still no effective diagnostic test, the root cause is unknown, and response to treatment is unpredictable.
The immune system, and particularly chronic inflammation, is believed to play a role in IBS. However, tools used to study the immune response lacked the depth and sensitivity.
Omniscope's technology offers unprecedented insights into the dynamics of the immune response.
The immune system, and particularly chronic inflammation, is believed to play a role in IBS. However, tools used to study the immune response lacked the depth and sensitivity.
Omniscope's technology offers unprecedented insights into the dynamics of the immune response.
You can take part if you meet all of the following:
You will be asked to complete a questionnaire regarding your experience as a patient.
Instructions will be provided to collect blood samples so that we can study your immune cells free of charge. Information will be provided once you have completed sign up. Your information will be treated in compliance with the law.
Omniscope lives by "Healthcare for everyone, everywhere". Therefore, as part of our social responsibility, we want to accelerate research into diagnosis and therapy for IBS. Our goal is to enable diagnostics and patient response to therapy.
Participant's immune response and analysis will be fully funded, and all data will be shared with you. Due to funding restrictions, places are limited to solely 30 participants.
You are invited to be part of this 30-strong group. Together we can as: "Science is we all."
The deadline for submission is 1 November 2023.
